An2 Therapeutics Inc (ANTX): Congress and insider trades
Who in Congress and inside the company traded ANTX, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- An2 Therapeutics Inc (ANTX) is a listed stock on NASDAQ.
- Insiders filed 1 open market buy worth $11.6K and 7 sells worth $344K, the latest filed 2026-09-11 (11 September 2026).
- Data as of 2026-09-29 (29 September 2026).
Insider trades in ANTX
as of 2026-09-11| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 11 Sep 2026 | Readnour Robin Shane | sell | 1,108 | $6.02 | $6.7K | n/a |
| 8 Sep 2026 | Readnour Robin Shane | sell | 6,100 | $6.07 | $37.0K | n/a |
| 8 Sep 2026 | Readnour Robin Shane | sell | 10,019 | $6.02 | $60.3K | n/a |
| 4 Sep 2026 | Williams Sarah Joanne | sell | 272 | $5.53 | $1.5K | n/a |
| 2 Sep 2026 | FitzPatrick Margaret M | buy | 2,098 | $5.53 | $11.6K | n/a |
| 19 Aug 2026 | Readnour Robin Shane | sell | 35,402 | $6.01 | $213K | n/a |
| 10 Jul 2026 | Eizen Joshua M | sell | 5,945 | $4.17 | $24.8K | n/a |
| 2 Jun 2026 | Williams Sarah Joanne | sell | 265 | $4.43 | $1.2K | n/a |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought ANTX?
0 Congress buys by 0 members and 1 insider buy are on file. The tables on this page list every one.
Did buying ANTX after a disclosure beat the market?
No disclosed buy of this stock has matured 90 days yet. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.